Epidemiology and practice patterns of achalasia in Taiwan: A nationwide population-based cohort study.

IF 2.4
Kai-Liang Lin, Wei-Yu Lin, Yen-Po Wang, Jiing-Chyuan Luo, Ming-Chih Hou, Hui-Chu Lang, Ching-Liang Lu
{"title":"Epidemiology and practice patterns of achalasia in Taiwan: A nationwide population-based cohort study.","authors":"Kai-Liang Lin, Wei-Yu Lin, Yen-Po Wang, Jiing-Chyuan Luo, Ming-Chih Hou, Hui-Chu Lang, Ching-Liang Lu","doi":"10.1097/JCMA.0000000000001214","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Achalasia is a rare disease of gastrointestinal motility characterized by impaired esophageal peristalsis and reduced esophageal sphincter relaxation. However, data on its epidemiology and outcomes in Taiwan are limited. This study aimed to assess the incidence, characteristics, and clinical management of achalasia in Taiwan.</p><p><strong>Methods: </strong>Patients who were newly diagnosed with achalasia between 2001 and 2013 were recruited from the Taiwan National Health Insurance Research Database. The study obtained data on the age, sex, urbanization, socioeconomic status, area of residence, diagnostic methods, and interventional management of the patients. Incidence, diagnostic modalities, treatment methods, malignancy, and mortality outcomes were analyzed.</p><p><strong>Results: </strong>In total, 206 new achalasia cases were identified. The mean annual incidence in Taiwan was 1.64 (95% confidence interval, 1.22-2.05) per 100 000 persons. The mean age of the patients at diagnosis was 51.8 years. The age-specific incidence of achalasia peaked in patients aged between 70 and 80 years and above 80 years. For achalasia diagnosis, endoscopy, computed tomography (CT), barium studies, and manometry were performed in 123 (59.71%), 97 (47.09%), 49 (23.79%), and 11 patients (5.34 %), respectively. During long-term follow-up, seven patients (3.39%) developed esophageal cancer, and 39 patients (18.93%) died. The median survival was 10.65 years after achalasia diagnosis, with a 10-year survival rate of 76.22%.</p><p><strong>Conclusion: </strong>This is the first population-based epidemiological study on achalasia in Taiwan, revealing the incidence of achalasia before the era of high-resolution manometry. Clinicians should be vigilant about the development of esophageal cancer and mortality during long-term follow-ups. There is also room to enhance the utilization of various diagnostic tools for achalasia.</p>","PeriodicalId":94115,"journal":{"name":"Journal of the Chinese Medical Association : JCMA","volume":" ","pages":"383-388"},"PeriodicalIF":2.4000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Chinese Medical Association : JCMA","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/JCMA.0000000000001214","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/7 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Achalasia is a rare disease of gastrointestinal motility characterized by impaired esophageal peristalsis and reduced esophageal sphincter relaxation. However, data on its epidemiology and outcomes in Taiwan are limited. This study aimed to assess the incidence, characteristics, and clinical management of achalasia in Taiwan.

Methods: Patients who were newly diagnosed with achalasia between 2001 and 2013 were recruited from the Taiwan National Health Insurance Research Database. The study obtained data on the age, sex, urbanization, socioeconomic status, area of residence, diagnostic methods, and interventional management of the patients. Incidence, diagnostic modalities, treatment methods, malignancy, and mortality outcomes were analyzed.

Results: In total, 206 new achalasia cases were identified. The mean annual incidence in Taiwan was 1.64 (95% confidence interval, 1.22-2.05) per 100 000 persons. The mean age of the patients at diagnosis was 51.8 years. The age-specific incidence of achalasia peaked in patients aged between 70 and 80 years and above 80 years. For achalasia diagnosis, endoscopy, computed tomography (CT), barium studies, and manometry were performed in 123 (59.71%), 97 (47.09%), 49 (23.79%), and 11 patients (5.34 %), respectively. During long-term follow-up, seven patients (3.39%) developed esophageal cancer, and 39 patients (18.93%) died. The median survival was 10.65 years after achalasia diagnosis, with a 10-year survival rate of 76.22%.

Conclusion: This is the first population-based epidemiological study on achalasia in Taiwan, revealing the incidence of achalasia before the era of high-resolution manometry. Clinicians should be vigilant about the development of esophageal cancer and mortality during long-term follow-ups. There is also room to enhance the utilization of various diagnostic tools for achalasia.

台湾失弛缓症的流行病学与实践模式:一项全国人口为基础的队列研究。
背景:贲门失弛缓症是一种罕见的胃肠运动疾病,其特征是食管蠕动功能受损和食管括约肌松弛减弱。然而,台湾有关其流行病学和结果的数据有限。本研究旨在评估台湾失弛缓症的发生率、特征及临床处理。​研究收集了患者的年龄、性别、城市化程度、社会经济状况、居住地区、诊断方法和介入治疗等资料。分析了发病率、诊断方式、治疗方法、恶性肿瘤和死亡率结果。结果:共发现206例贲门失弛缓症新病例。台湾的年平均发病率为每10万人1.64例(95%可信区间1.22-2.05)。患者确诊时的平均年龄为51.8岁。贲门失弛缓症的年龄特异性发病率在70-80岁和80岁以上的患者中达到高峰。对于贲门失弛缓症的诊断,分别有123例(59.71%)、97例(47.09%)、49例(23.79%)和11例(5.34%)患者进行了内窥镜检查、CT检查、钡检查和测压检查。长期随访中,7例(3.39%)发生食管癌,39例(18.93%)死亡。失弛缓症诊断后的中位生存期为10.65年,10年生存率为76.22%。结论:本研究为台湾首次以人群为基础的失弛缓症流行病学研究,揭示了高分辨率测压法时代之前失弛缓症的发病率。临床医生应在长期随访中警惕食管癌的发展和死亡率。对贲门失弛缓症的各种诊断工具的利用也有提高的空间。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信